Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.
Saved in:
| Title: | Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia. |
|---|---|
| Authors: | Carreño-Tarragona G; Hematology Department. Hospital Universitario 12 de Octubre, imas12, CNIO, Complutense University, CIBERONC, Madrid, Spain. gonzalo.carreno@salud.madrid.org., Gil-Manso R; Hematology Department. Hospital Clínico Universitario, Salamanca, Spain., Hernández-Boluda JC; Hematology Department. Hospital Clínico, Valencia, Spain., Martínez-Ávila JC; Departamento de Economía Agraria, Estadística y Gestion de Empresas, Escuela Técnica Superior de Ingeniería Agronómica, Alimentaria y Biosistemas, Universidad Politécnica de Madrid, Madrid, Spain., Bellosillo B; Pathology Department. Hospital del Mar, IMIM, Barcelona, Spain., Pérez-López R; Hematology Department. Hospital Virgen de la Arrixaca, IMIB Murcia, Murcia, Spain., Segura A; Hematology Department. Hospital Universitario de Gran Canaria Dr. Negrín, Instituto de Investigación Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain., Ferrer-Marín F; Hematology Department. Hospital Morales Meseguer, CIBERER, UCAM, Murcia, Spain., Arellano-Rodrigo E; Hematology Department. Hospital Clínic, Barcelona, Spain., Angona A; Hematology Department. Hospital Doctor Josep Trueta, Girona, Spain., García-Gutiérrez V; Hematology Department. Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria. Universidad de Alcalá, Madrid, Spain., Noya MS; Hematology Department. Complexo Hospitalario Universitario de A Coruña, Coruña, Spain., Blanco Á; Hematology Department. Hospital Universitario 12 de Octubre, imas12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Zamora L; Hematology Laboratory Department, Institut Català d'Oncologia (ICO), Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain., Navarro M; Hematology Department. Hospital Universitario 12 de Octubre, imas12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Senín A; Hematology Department. Hospital del Mar, IMIM, Barcelona, Spain., Magro E; Hematology Department. Hospital Príncipe de Asturias, Alcalá de Henares, Spain., Pastor-Galán I; Hematology Department. Hospital Clínico, Valencia, Spain., Mata-Vázquez MI; Hematology Department. Hospital Universitario Costa del Sol, Marbella, Spain., Morales ML; Hematology Department. Hospital Morales Meseguer, CIBERER, UCAM, Murcia, Spain., Cuevas B; Hematology Department. Hospital Universitario de Burgos, Instituto de Investigación Biosanitaria de Burgos (IBioBurgos), Burgos, Spain., Vélez P; Hematology Department. Hospital del Mar, IMIM, Barcelona, Spain., Mora E; Hematology Department. Hospital Universitario La Fe, Valencia, Spain., Martínez-Bilbao C; Hematology Department. Hospital Galdakao-Usansolo, Galdakao, Spain., Colmenares R; Hematology Department. Hospital Universitario 12 de Octubre, imas12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Alonso JM; Hematology Department. Hospital Fundación Jimñenez-Díaz, Madrid, Spain., Pérez-Encinas M; Hematology Department. Hospital Clínico Universitario de Santiago de Compostela, USC, A Coruña, Spain., Caballero-Navarro G; Hematology Department. Hospital Miguel Servet, Zaragoza, Spain., Cortés MÁ; Hematology Department. Hospital Marqués de Valdecilla, Santander, Spain., Santaliestra M; Hematology Department. Hospital Universitari Mútua Terrasa, Terrasa, Spain., Raya JM; Hematology Department, Hospital Universitario de Canarias, Tenerife, Spain., Blanco-Sánchez A; Hematology Department. Hospital Universitario 12 de Octubre, imas12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Hernández-Rivas JM; Hematology Department. Hospital Clínico Universitario, Salamanca, Spain.; Universidad de Salamanca, IBSAL, IBMCC, CSIC, Centro de Investigación del Cáncer, Salamanca, Spain., Martínez-López J; Hematology Department. Hospital Universitario 12 de Octubre, imas12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Ayala R; Hematology Department. Hospital Universitario 12 de Octubre, imas12, CNIO, Complutense University, CIBERONC, Madrid, Spain., Álvarez-Larrán A; Hematology Department. Hospital Clínic, Barcelona, Spain. |
| Corporate Authors: | MPN Spanish Group (GEMFIN) |
| Source: | Leukemia [Leukemia] 2026 Jul 13. Date of Electronic Publication: 2026 Jul 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
